Indication

Haemophilia B

1 clinical trial

1 product

Clinical trial
Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
Status: Active (not recruiting), Estimated PCD: 2022-07-12
Product
Concizumab